AXP officer reports 52,395 performance options at $148.45
Rhea-AI Filing Summary
American Express (AXP) reported a Form 4 for an officer (Pres., Enterprise Shared Serv.) showing an acquisition of 52,395 employee stock options on 10/31/2025. The options carry a $148.45 exercise price, become exercisable on 10/31/2026, and expire on 10/31/2029. Following the transaction, the reporting person directly holds 52,395 derivative securities.
The filing notes these relate to a Performance Stock Option award granted in October 2022, of which 75% has vested based on specified performance criteria. The remaining 25% is contingent on meeting performance goals and the reporting person’s continued employment through October 31, 2026.
Positive
- None.
Negative
- None.
Insights
Routine equity award vesting; neutral impact.
The Form 4 records acquisition of 52,395 employee stock options at an exercise price of $148.45. These options are scheduled to be exercisable beginning 10/31/2026 and expire on 10/31/2029. This aligns with typical multi-year equity compensation structures for senior executives.
The narrative states 75% of the performance options vested based on predefined criteria from the October 2022 grant, with the remaining 25% tied to future performance and continued employment through 10/31/2026. There is no cash flow to the issuer at grant; any proceeds would arise only upon potential future exercise at the stated price.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 52,395 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
What did American Express (AXP) disclose in this Form 4?
When do the AXP options become exercisable and when do they expire?
How much of the AXP performance award has vested?
What conditions remain on the unvested AXP options?
How many derivative securities does the reporting person hold after the AXP transaction?
Does American Express receive proceeds from this Form 4 event?